A number of other analysts have also recently issued reports on the company. DZ Bank reaffirmed a buy rating on shares of Swiss Re in a research report on Tuesday, January 16th. UBS set a CHF 84 price objective on Swiss Re and gave the company a sell rating in a research report on Friday, January 5th. Goldman Sachs set a CHF 95 price objective on Swiss Re and gave the company a neutral rating in a research report on Thursday, December 7th. Commerzbank set a CHF 98 price objective on Swiss Re and gave the company a sell rating in a research report on Monday, January 22nd. Finally, JPMorgan Chase set a CHF 110 price objective on Swiss Re and gave the company a buy rating in a research report on Monday, February 26th. Three analysts have rated the stock with a sell rating, nine have assigned a hold rating and ten have issued a buy rating to the company’s stock. The stock presently has an average rating of Hold and an average target price of CHF 98.25.
VTX:SREN opened at CHF 97.12 on Thursday. Swiss Re has a 12-month low of CHF 81.65 and a 12-month high of CHF 98.80.
About Swiss Re
Swiss Re AG is a wholesale provider of reinsurance, insurance and other insurance-based forms of risk transfer. The Company operates in four segments: Property&Casualty Reinsurance, Life&Health Reinsurance, Corporate Solutions and Life Capital. Its Reinsurance Unit provides premiums and fee income through Property&Casualty and Life&Health segments.
Receive News & Ratings for Swiss Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Swiss Re and related companies with MarketBeat.com's FREE daily email newsletter.